News Archives | Future Medicine India


Nasal spray treatment cuts SARS CoV-2 levels in nose and throat by 96%

A new nasal spray dubbed INNA-051 has shown to significantly mitigate SARS-CoV-2 virus levels in the nose and throat by up to 96% in an animal-based study, announced Australian biotech company Ena Respiratory.

Read More..

NMC overtakes medical education regulations from MCI

The Union health ministry has notified the National Medical Commission (NMC) as regulatory body of medical education and practice in India following the abolishing of Medical Council of India (MCI)


Metformin treatment linked to slowed cognitive decline

Metformin, the first-line treatment for most cases of type 2 diabetes was found to be associated with slowing the cognitive decline, according to a recent observational study published in the journal Diabetes Care.


National Medical Commission approves MD Laboratory Medicine

The National Medical Commission, formerly known as Medical Council of India, has given recognition to MD course in Laboratory Medicine by its inclusion in the Post Graduate Medical Education Regulations, 2000.


Wipro GE Healthcare, IISc jointly launches Healthcare Innovation Lab

Wipro GE Healthcare in collaboration with the Indian Institute of Science (IISc) has launched an advanced center for innovation and research at the IISc campus in Bangalore.


India’s COVID caseload crosses 58 lakh on Thursday; 1144 new deaths

India reported 85,919 fresh COVID-19 cases and 1,144 deaths on Thursday. With this, the COVID caseload in the country has crossed the 58 lakh mark to reach 5,816,103


Glucocorticoids could worsen COVID-19 outcomes in arthritis patients

The outcomes of COVID-19 infection may be worse among patients with inflammatory arthritis receiving glucocorticoids, but not in those receiving anti-cytokine therapy, find researchers from the New York University School of Medicine.